Prediction of changes in levels of haemostatic variables during natural menstrual cycle and ovarian hyperstimulation

Thrombosis and Haemostasis

Volumn 77, Issue 5, 1997, Pages 901-904

  Andersson, Ola ^a   Blombäck, Margareta ^b   Bremme, Katarina ^b   Wramsby, Hâkan ^b  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; ESTRADIOL; FIBRINOGEN; HUMAN MENOPAUSAL GONADOTROPIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGESTERONE; PROTEIN C; PROTEIN S; VON WILLEBRAND FACTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HORMONAL REGULATION; HUMAN; MENSTRUAL CYCLE; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS;

EID: 1842328611     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1656075     Document Type: Article

References (9)

1. Blombäck M, Hall K, Ritzén M. Estrogen treatment of tall girls: risk of thrombosis? Pediatrics 1983; 72: 416-9.
2. Blombäck M, Eneroth P, Landgren BM, Lagerström M, Andersson O. On the intraindividual and gender variability of haemostatic components. Thromb Haemost 1992; 67: 70-5.
3. Bremme K, Wramsby H, Andersson O, Wallin M, Blombäck M. Do lowered factor VII levels at extremely high endogenous oestradiol levels protect against thrombin formation? Blood Coagulation and Fibrinolysis 1994; 5: 205-10.
4. Bonnar J. Coagulation effects of oral contraception. Am J Obstetr Gynecol 1987; 157: 1042-8.
5. Blombäck M. Changes in blood coagulation and fibrinolysis during pregnancy and the menstrual cycle, new methods for detecting the changes. Oral contraceptives and cardiovascular disease. Advances in Contraception Zatuchni, GI, Elstein M eds. Kluwer Academic Publishers, London. 1991; 7: Suppl 3: pp 259-72.
6. Scarabin PY, Plu-Bureau G, Bara L, Bonithon-Kopp C, Guize L. Samama MM. Haemostatic variables and menopausal status: influence of hormone replacement therapy. Thromb Haemost 1993; 70: 584-7.
7. Robinson GE. Low dose combined oral contraceptives Brit J Obstetr Gynaecol 1994; 101: 1036-41.
8. Stampfer MJ, Colditz GA, Willett C, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. New Engl J Medicine 1991; 325: 756-62.
9. Hamsten A, Blombäck M, Wiman B, Svensson J, Szamosi A, de Faire U, Mettinger M. Haemostatic function in myocardial infarction. Br Heart J 1986; 55: 58-66.